ClinicalTrialsFinder

Immune Checkpoint Inhibitors Clinical Trials in Ottawa, Ontario

1 recruitingOttawa, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 3

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Urinary Bladder NeoplasmsImmune Checkpoint InhibitorsMethotrexate+4 more
AstraZeneca150 enrolled59 locationsNCT06960577